SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001640334-19-001577
Filing Date
2019-08-09
Accepted
2019-08-09 16:58:07
Documents
2
Period of Report
2019-07-25
Effectiveness Date
2019-08-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A inmb_def14a.htm DEF 14A 689716
2 inmb_pre14aimg1.jpg GRAPHIC 11350
  Complete submission text file 0001640334-19-001577.txt   706546
Mailing Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037
Business Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38793 | Film No.: 191013615
SIC: 2836 Biological Products, (No Diagnostic Substances)